In part 5 of this exclusive video, DIC publisher Steve Freed concludes his discussion with Dr. George Bakris about the use of an at-home kidney test as one method of early capture of possible kidney disease.
Read More »George Bakris, MD
Dr. George Bakris Part 4, The Meaning of False Positives in an At-Home Kidney Test
In part 4 of this exclusive video, Dr. Bakris contemplates the rate of potential false positives in an at-home kidney test for microalbuminuria, the possible causes of false positives and the need for patient education in the use of such tests.
Read More »Dr. George Bakris Part 3, An Idea for an At-Home Kidney Test
In part 3 of this exclusive video, DIC publisher Steve Freed talks with Dr. George Bakris about an idea to create an at-home test to screen for possible kidney disease.
Read More »George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 6 of 6
This week George Bakris, MD, does some quick math to determine the cost of diabetes as it relates to dialysis and contemplates the future of dialysis equipment. He also shares current dialysis treatment options that may offer some flexibility to patient currently bound to visiting treatment centers....
Read More »George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 5 of 6
This week George Bakris, MD, explains microalbuminuria as a sign of kidney disease and how often to test for it. He also ponders the questions of how do you determine if the patient is at risk for nephropathy and what do you do if they are....
Read More »George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 4 of 6
This week George Bakris, MD, does some quick math to determine the cost of diabetes as it relates to dialysis and contemplates the future of dialysis equipment. He also shares current dialysis treatment options that may offer some flexibility to patient currently bound to visiting treatment centers….
Read More »George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 3 of 6
George Bakris, MD, continues his discussion with Diabetes in Control Publisher Steve Freed. This week, the focus is why certain ethnic groups are more suscepticle to developing kidney disease, with or without diabetes. With the detection of the gene leading to kidney disease, more aggressive preventative treatment can be implemented …
Read More »George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 2 of 6
George Bakris, MD, continues his discussion with Diabetes in Control Publisher Steve Freed on lowering blood pressure and the “white coat” effect. Is this something that can be overcome? Dr. Bakris shares some interesting findings…
Read More »George Bakris, MD: SGLT2 Mechanism for BP Reduction Part 1 of 6
George Bakris, MD, sits down with Diabetes in Control Publisher Steve Freed to discuss the effects of SGLT2 drugs on the kidneys and how it can be effective at dispelling sodium and lowering the blood pressure. He also talks about another method of blood pressure monitoring that gives a more …
Read More »New Drug Prevents Hyperkalemia Associated with Treatment for Chronic Diabetic Kidney Disease
Patiromer can normalize moderate hyperkalemia, lower potassium levels in as little as 4 weeks…
Read More »